Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Cash flows from operating activities:
Net loss	$ (10,603,477)	$ (9,659,918)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	1,630,011	2,080,319
Amortization of debt discount	270,236	121,997
Depreciation expense	4,735	3,155
Operating lease expense	0	60,257
Finance lease depreciation expense	9,670	10,957
Changes in assets and liabilities:
Prepaid expenses and other assets	443,210	(113,758)
Accounts payable	(981,993)	852,774
Accrued expenses	(710,581)	(6,455,317)
Operating lease liabilities	0	(89,102)
Net cash used in operating activities	(9,938,189)	(13,188,636)
Cash flows from financing activities:
Proceeds from exercise of stock options	531,091	0
Payments of finance lease obligations	(13,475)	(20,667)
Proceeds from issuance of common stock, net of issuance costs	19,494,473	4,588,522	$ 16,100,000
Net cash provided by financing activities	20,012,089	4,567,855
Net (decrease) increase in cash and cash equivalents	10,073,900	(8,620,781)
Cash and cash equivalents at beginning of period	56,560,517	73,820,160	73,820,160
Cash and cash equivalents at the end of period	66,634,417	65,199,379	$ 56,560,517
Supplemental information of cash and non-cash transactions:
Cash paid for interest	$ 1,174,745	$ 966,845